William D. Schaeffer
Geschäftsführer bei Carmel Biosciences, Inc.
Aktive Positionen von William D. Schaeffer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Carmel Biosciences, Inc.
 Carmel Biosciences, Inc. BiotechnologyHealth Technology Carmel Biosciences, Inc. engages in clinical research and small molecule discovery and development in the areas of prescription drugs and nutraceuticals. Its therapeutic indications include cardiovascular diseases, metabolic disorders, and lifestyle-related disorders. The company was founded in 2011 and is headquartered in Atlanta, GA. | Geschäftsführer | - | - |
Karriereverlauf von William D. Schaeffer
Ehemalige bekannte Positionen von William D. Schaeffer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Saint Joseph’s Translational Research Institute | Präsident | - | - |
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Corporate Officer/Principal | - | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Forticell Bioscience, Inc.
 Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Geschäftsführer | - | - |
| CIBA Vision, Inc. | Corporate Officer/Principal | - | - |
InVasc Therapeutics, Inc.
 InVasc Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology InVasc Therapeutics, Inc. engages in the development of drugs for treating and preventing cardio metabolic disease. It specializes in target-specific drug discovery with several potential drug therapies at the pre-clinical stage. The company was founded in 2006 and is headquartered in Tucker, GA. | Direktor/Vorstandsmitglied | 01.03.2009 | - |
| Geschäftsführer | 12.07.2010 | - |
Ausbildung von William D. Schaeffer
| Bucknell University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 3 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 6 |
|---|---|
InVasc Therapeutics, Inc.
InVasc Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology InVasc Therapeutics, Inc. engages in the development of drugs for treating and preventing cardio metabolic disease. It specializes in target-specific drug discovery with several potential drug therapies at the pre-clinical stage. The company was founded in 2006 and is headquartered in Tucker, GA. | Health Technology |
| CIBA Vision, Inc. | |
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
| Saint Joseph’s Translational Research Institute | |
Carmel Biosciences, Inc.
Carmel Biosciences, Inc. BiotechnologyHealth Technology Carmel Biosciences, Inc. engages in clinical research and small molecule discovery and development in the areas of prescription drugs and nutraceuticals. Its therapeutic indications include cardiovascular diseases, metabolic disorders, and lifestyle-related disorders. The company was founded in 2011 and is headquartered in Atlanta, GA. | Health Technology |
- Börse
- Insiders
- William D. Schaeffer
- Erfahrung
